Analysis and Perspectives

Mar 25, 2026

DelveInsight estimates that the total market size for hypophosphatasia in the 7MM was nearly $1 billion in 2023, and it is expected to grow at a CAGR of 7.2% by 2034. This growth is anticipated to be driven by the introduction of new therapies, such as AstraZeneca’s ALXN1850 (efzimfotase alfa), AM Pharma’s Ilofotase alfa, and others, and increased disease awareness.

Mar 25, 2026

Future of nephrotic syndrome treatment holds promise advancements in precision medicine as the market size in 7MM to grow from $401M in 2022.

Mar 18, 2026

Potential therapies are being investigated for retinal vein occlusion treatment. Even though it is too soon to comment on the promising candidate to enter the market, it is safe to assume that the future of the retinal vein occlusion treatment market is promising.

Mar 17, 2026

Exosome-based therapies represent a promising frontier in regenerative medicine and targeted drug delivery, with the potential to revolutionize the treatment of various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases.

Feb 09, 2026

The role and application of Artificial Intelligence have grown at an immense pace in recent years. Globally, several companies, including large & small scale businesses, education, retail, and telecommunications, among others, are actively exploring opportunities to leverage the potential of AI in their organiz...

Nov 04, 2025

Owing to the presence of global MedTech giants such as GE Healthcare, Hologic, and others, the Bone Densitometers Market is highly competitive

Nov 04, 2025

Nanomedicine Market prospects are growing at an immense rate. Nanomedicine provides several benefits, and the applications are evolving.

Aug 28, 2025

The real-world use cases of Robotic Process Automation in Healthcare are creating a significant impact on the appointment, treatment, claims

Aug 27, 2025

The global healthcare landscape is witnessing a seismic shift, propelled by the rapid integration of smart healthcare technology into everyday medical practice. At the forefront of this transformation are smart medical devices are intelligent tools that combine advanced sensors, wireless connectivity, data analytic...

Aug 22, 2025

Vertex & CRISPR Therapeutics become first companies to submit marketing application for CRISPR gene-editing therapy exa-cel for SCD & TDT.